Lipocine (LPCN) Institutional Ownership $3.31 +0.05 (+1.53%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Lipocine (NASDAQ:LPCN)CurrentInstitutional OwnershipPercentage9.11%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$151.56KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$20.98K Get LPCN Insider Trade Alerts Want to know when executives and insiders are buying or selling Lipocine stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LPCN Institutional Buying and Selling by Quarter Lipocine Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2025Renaissance Technologies LLC36,032$176K0.0%-10.7%0.673% 2/12/2025Geode Capital Management LLC57,464$280K0.0%+6.0%1.074% 8/9/2024Renaissance Technologies LLC25,697$212K0.0%+21.8%0.480% 8/9/2024Dimensional Fund Advisors LP11,870$98K0.0%N/A0.222% 1/29/2024 Wealth Effects LLC14,639$41K0.0%-22.0%0.275% 10/16/2023 Wealth Effects LLC18,761$56K0.0%-35.9%0.353% 7/18/2023 Wealth Effects LLC29,273$148K0.1%-96.1%0.563% 6/5/2023EP Wealth Advisors LLC66,983$13.40M0.2%N/A1.288% 5/4/2023 Wealth Effects LLC756,674$241K0.1%-35.8%0.855% 2/13/2023 Wealthspan Partners LLC73,950$29K0.0%N/A0.084% Get the Latest News and Ratings for LPCN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lipocine and its competitors with MarketBeat's FREE daily newsletter. 2/2/2023 Wealth Effects LLC1,178,834$469K0.3%-3.0%1.332% 2/2/2023Bailard Inc.82,957$32K0.0%N/A0.094% 11/7/2022Virtu Financial LLC93,411$42K0.0%N/A0.106% 8/3/2022Carson Advisory Inc.52,000$42K0.0%N/A0.059% 7/27/2022Bailard Inc.74,400$60K0.0%N/A0.084% 7/22/2022 Aaron Wealth Advisors LLC145,045$116K0.0%+23.4%0.164% 5/13/2022EAM Investors LLC657,804$901K0.2%N/A0.743% 5/10/2022 Aaron Wealth Advisors LLC117,552$85.81M1.2%N/A0.133% 4/26/2022Kestra Advisory Services LLC307,300$421K0.0%+27.9%0.347% 2/14/2022GSA Capital Partners LLP440,432$437K0.1%+39.7%0.499% 2/9/2022 Wealth Effects LLC1,489,434$1.48M0.6%N/A1.687% 11/15/2021GSA Capital Partners LLP315,308$344K0.0%+122.8%0.357% 11/10/2021Mercer Global Advisors Inc. ADV313,111$341K0.0%+6.8%0.355% 11/9/2021Barclays PLC24,075$26K0.0%+243.3%0.027% 10/19/2021Kestra Advisory Services LLC249,418$272K0.0%+256.3%0.282% 8/16/2021State Street Corp304,617$426K0.0%+2,356.6%0.345% 8/13/2021Northern Trust Corp173,117$242K0.0%+16.8%0.196% 8/13/2021LPL Financial LLC62,750$88K0.0%+46.8%0.071% 8/13/2021Geode Capital Management LLC760,586$1.06M0.0%+26.0%0.861% 8/13/2021Vanguard Group Inc.3,815,348$5.34M0.0%+6.4%4.321% 8/12/2021XTX Topco Ltd20,706$29K0.0%-30.8%0.023% 8/11/2021 Bank of New York Mellon Corp110,204$154K0.0%+99.6%0.125% 8/11/2021BlackRock Inc.1,582,415$2.22M0.0%-2.5%1.792% 8/10/2021Mercer Global Advisors Inc. ADV293,111$410K0.0%+38.8%0.332% 8/10/2021 Principal Financial Group Inc.20,382$29K0.0%N/A0.023% 8/5/2021GSA Capital Partners LLP141,521$198K0.0%+12.3%0.160% 5/19/2021Virtu Financial LLC191,387$289K0.0%-8.0%0.217% 5/19/2021Squarepoint Ops LLC84,001$127K0.0%+515.5%0.095% 5/18/2021Cubist Systematic Strategies LLC55,200$83K0.0%N/A0.063% 5/18/2021Jane Street Group LLC29,060$44K0.0%N/A0.033% The Man I Turn to In Times Like This (Ad)A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.Market chaos? Hear Tilson’s take now5/17/2021Price T Rowe Associates Inc. MD89,264$135K0.0%N/A0.101% 5/17/2021Ameriprise Financial Inc.702,000$1.06M0.0%-4.2%0.795% 5/14/2021MML Investors Services LLC41,000$62K0.0%N/A0.046% 5/14/2021XTX Topco Ltd29,929$45K0.0%N/A0.034% 5/13/2021Barclays PLC21,594$33K0.0%N/A0.024% 5/12/2021Northern Trust Corp148,222$224K0.0%+19.3%0.168% 5/12/2021Geode Capital Management LLC603,713$911K0.0%+33.9%0.684% 5/11/2021Mercer Global Advisors Inc. ADV211,210$319K0.0%-27.5%0.239% 5/10/2021GSA Capital Partners LLP125,993$190K0.0%-32.3%0.143% (Data available from 1/1/2016 forward) LPCN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LPCN shares? During the previous two years, the following institutional investors and hedge funds held shares of Lipocine shares: EP Wealth Advisors LLC ($13.40M), Geode Capital Management LLC ($280K), Renaissance Technologies LLC ($176K), and Dimensional Fund Advisors LP ($98K), Wealth Effects LLC ($41K).Learn more on LPCN's institutional investors. What percentage of Lipocine stock is owned by institutional investors? 9.11% of Lipocine stock is owned by institutional investors. Learn more on LPCN's institutional investor holdings. Which institutional investors have been buying Lipocine stock? The following institutional investors have purchased Lipocine stock in the last 24 months: EP Wealth Advisors LLC ($66.98K), Dimensional Fund Advisors LP ($11.87K), Renaissance Technologies LLC ($4.60K), and Geode Capital Management LLC ($3.25K). How much institutional buying is happening at Lipocine? Institutional investors have bought a total of 86,701 shares in the last 24 months. This purchase volume represents approximately $513.79K in transactions. Which Lipocine major shareholders have been selling company stock? The following institutional investors have sold Lipocine stock in the last 24 months: Wealth Effects LLC ($1.16M), and Renaissance Technologies LLC ($4.30K). How much institutional selling is happening at Lipocine? Institutional investors have sold a total of 1,168,495 shares in the last 24 months. This volume of shares sold represents approximately $6.01M in transactions. Related Companies ABOS Major Shareholders RENB Major Shareholders INZY Major Shareholders VTVT Major Shareholders RANI Major Shareholders ANRO Major Shareholders MGX Major Shareholders ADAP Major Shareholders CLSD Major Shareholders INCR Major Shareholders This page (NASDAQ:LPCN) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lipocine Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lipocine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LPCN Stock Free LPCN Stock Alerts